HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirokazu Taniguchi Selected Research

Doxorubicin (Adriamycin)

1/2021Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.
3/2017Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment.
5/2015Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus.
12/2010Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.
4/2002[A case of effective paclitaxel therapy for adriamycin resistant metastatic breast cancer with brain metastases].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirokazu Taniguchi Research Topics

Disease

97Neoplasms (Cancer)
02/2024 - 01/2002
51Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2002
28Neoplasm Metastasis (Metastasis)
01/2022 - 04/2002
24Lung Neoplasms (Lung Cancer)
11/2023 - 07/2015
22Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2007
18Adenocarcinoma
12/2020 - 09/2007
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 03/2005
16Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 09/2014
16Carcinoma (Carcinomatosis)
11/2023 - 01/2003
12Lymphatic Metastasis
02/2019 - 01/2002
10Asthma (Bronchial Asthma)
11/2019 - 05/2002
10Breast Neoplasms (Breast Cancer)
11/2015 - 02/2002
9Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2007
9Adenoma (Adenomas)
04/2020 - 09/2012
8Adenocarcinoma of Lung
01/2022 - 09/2012
6Disease Progression
10/2023 - 02/2009
6Rectal Neoplasms (Rectal Cancer)
12/2021 - 11/2007
6Pneumonia (Pneumonitis)
01/2021 - 07/2003
5Brain Neoplasms (Brain Tumor)
05/2023 - 04/2002
5Lymphoma (Lymphomas)
01/2022 - 01/2009
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 12/2010
5Chest Pain (Chest Pains)
06/2017 - 11/2007
5Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2016 - 01/2009
4Neuroendocrine Carcinoma
10/2022 - 06/2011
4B-Cell Lymphoma (Lymphoma, B Cell)
02/2021 - 10/2004
4Ileus
01/2021 - 10/2003
4Polyps
04/2020 - 10/2017
4Carcinogenesis
01/2018 - 01/2002
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2016 - 01/2009
4Tuberculosis (Tuberculoses)
02/2009 - 08/2003
3Hodgkin Disease (Hodgkin's Disease)
02/2024 - 10/2015
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2024 - 01/2013
3Hypoxia (Hypoxemia)
01/2023 - 10/2002
3Edema (Dropsy)
01/2022 - 11/2013
3Obesity
01/2022 - 01/2016
3Thrombosis (Thrombus)
12/2021 - 11/2011
3Residual Neoplasm
01/2021 - 02/2009
3Fibrosis (Cirrhosis)
01/2020 - 11/2013
3Pleural Effusion (Pleural Effusions)
01/2020 - 02/2009

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2003
16Cisplatin (Platino)FDA LinkGeneric
01/2024 - 11/2002
11Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2006
10Etoposide (VP 16)FDA LinkGeneric
01/2024 - 12/2010
9Rituximab (Mabthera)FDA Link
02/2021 - 01/2009
8Immune Checkpoint InhibitorsIBA
01/2024 - 10/2018
8Paclitaxel (Taxol)FDA LinkGeneric
08/2023 - 02/2002
8Carboplatin (JM8)FDA LinkGeneric
08/2023 - 09/2014
8amrubicinIBA
10/2022 - 09/2014
7Irinotecan (Camptosar)FDA LinkGeneric
10/2023 - 06/2011
7Anaplastic Lymphoma KinaseIBA
01/2023 - 06/2014
7Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2013
7Prednisolone (Predate)FDA LinkGeneric
01/2021 - 07/2003
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 10/2007
6AcidsIBA
01/2022 - 08/2003
6osimertinibIBA
10/2021 - 12/2017
6Adrenal Cortex Hormones (Corticosteroids)IBA
04/2017 - 05/2002
6ParaffinIBA
11/2016 - 01/2013
6Formaldehyde (Formol)FDA Link
11/2016 - 01/2013
5pembrolizumabIBA
05/2024 - 02/2020
5PlatinumIBA
05/2024 - 01/2016
5atezolizumabIBA
03/2023 - 01/2022
5Bevacizumab (Avastin)FDA Link
01/2023 - 11/2010
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 11/2014
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 04/2002
5Docetaxel (Taxotere)FDA Link
01/2020 - 04/2011
5Trastuzumab (Herceptin)FDA Link
02/2019 - 08/2014
5NivolumabIBA
01/2019 - 11/2017
5CrizotinibIBA
01/2019 - 06/2014
5Fluorouracil (Carac)FDA LinkGeneric
05/2017 - 11/2002
4Pemetrexed (MTA)FDA Link
05/2024 - 11/2017
4B7-H1 AntigenIBA
05/2024 - 02/2020
4LigandsIBA
11/2023 - 07/2006
4ErbB Receptors (EGF Receptor)IBA
05/2023 - 01/2017
4Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 09/2009
4Capecitabine (Xeloda)FDA Link
01/2022 - 10/2014
4fibroblast growth factor 21IBA
01/2022 - 10/2014
4RNA (Ribonucleic Acid)IBA
05/2021 - 12/2003
4Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2010
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2010
4theasinensin AIBA
04/2020 - 10/2017
4Carcinoembryonic AntigenIBA
11/2019 - 11/2003
4Bronchodilator Agents (Bronchodilators)IBA
11/2019 - 09/2009
4Epstein-Barr virus encoded RNA 1IBA
07/2019 - 01/2013
4Phosphotransferases (Kinase)IBA
01/2019 - 11/2009
4Estrogen ReceptorsIBA
11/2014 - 11/2011
4Progesterone Receptors (Progesterone Receptor)IBA
11/2014 - 11/2011
4Messenger RNA (mRNA)IBA
09/2007 - 10/2003
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2023 - 11/2015
3lorlatinibIBA
05/2023 - 01/2019

Therapy/Procedure

57Therapeutics
05/2024 - 02/2002
53Drug Therapy (Chemotherapy)
01/2024 - 10/2003
19Gastrectomy
12/2021 - 10/2003
12Radiotherapy
01/2022 - 11/2010
12Lymph Node Excision (Lymph Node Dissection)
12/2021 - 01/2009
10Neoadjuvant Therapy
01/2021 - 11/2011
7Adjuvant Chemotherapy
12/2021 - 11/2007
7Colectomy
11/2016 - 08/2010
5Combination Drug Therapy (Combination Chemotherapy)
03/2023 - 10/2014
5Esophagectomy
01/2020 - 07/2008
5Chemoradiotherapy
11/2017 - 11/2010